Associations of posthemodialysis weights above and below target weight with all-cause and cardiovascular mortality

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 5, 2015, Pages 808-816

  Flythe, Jennifer E ^a,b   Kshirsagar, Abhijit V ^a   Falk, Ronald J ^a   Brunelli, Steven M ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DAVITA CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; TIME TO TREATMENT; WEIGHT GAIN; ADVERSE EFFECTS; AGED; CARDIOVASCULAR DISEASE; ELECTROLYTE BALANCE; EPIDEMIOLOGY; FOLLOW UP; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; ULTRAFILTRATION; UNITED STATES; WEIGHT REDUCTION;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; ULTRAFILTRATION; UNITED STATES; WATER-ELECTROLYTE BALANCE; WEIGHT GAIN; WEIGHT LOSS;

EID: 84929224097     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10201014     Document Type: Article

References (23)

1. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222–1228, 2006
2. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced cardiac injury: Determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914–920, 2009
3. Zoccali C, Benedetto FA, Tripepi G, Mallamaci F: Cardiac consequences of hypertension in hemodialysis patients. Semin Dial 17: 299–303, 2004
4. Sharpe N: Left ventricular remodeling: Pathophysiology and treatment. Heart Fail Monit 4: 55–61, 2003
5. Burton JO, Korsheed S, Grundy BJ, McIntyre CW: Hemodialysisinduced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail 30: 701–709, 2008
6. Chen PS, Chou CC, Tan AY, Zhou S, Fishbein MC, Hwang C, Karagueuzian HS, Lin SF: The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 17[Suppl 3]: S2–S7, 2006
7. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule. Fed Regist 73: 20369–20484, 2008
8. Movilli E, Camerini C, Gaggia P, Zubani R, Feller P, Poiatti P, Pola A, Carli O, Cancarini G: Magnitude of end-dialysis overweight is associated with all-cause and cardiovascular mortality: A 3-year prospective study. Am J Nephrol 37: 370–377, 2013
9. Biehl A, Hovengen R, Meyer HE, Hjelmesaeth J, Meisfjord J, Grøholt EK, Roelants M, Strand BH: Impact of instrument error on the estimated prevalence of overweight and obesity in population-based surveys. BMC Public Health 13: 146, 2013
10. Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, Chertow GM: Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol 22: 1526–1533, 2011
11. Chesterton LJ, Selby NM, Burton JO, McIntyre CW: Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 13: 189–196, 2009
12. Flythe J, Xue H, Lynch K, Curhan G, Brunelli S: Association of mortality risk with various definitions of intradialytic hypotension [published online ahead of print September 30, 2014]. J Am Soc Nephrol
13. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79: 250–257, 2011
14. López-Gómez JM, Villaverde M, Jofre R, Rodriguez-Benítez P, Pérez-García R: Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl (93): S63–S68, 2005
15. Manikandan S: Measures of central tendency: The mean. J Pharmacol Pharmacother 2: 140–142, 2011
16. McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, Izumo S: Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109: 3050–3055, 2004
17. Cotter G, Felker GM, Adams KF, Milo-Cotter O, O’Connor CM: The pathophysiology of acute heart failure–is it all about fluid accumulation? Am Heart J 155: 9–18, 2008
18. Ritz E, Wanner C: The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 3: 920–929, 2008
19. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4: 1925–1931, 2009
20. Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A: Association of provider-patient visit frequency and patient outcomes on hemodialysis. J Am Soc Nephrol 23: 1560–1567, 2012
21. Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J: Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol 25: 2079–2087, 2014
22. Passauer J, Petrov H, Schleser A, Leicht J, Pucalka K: Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: A cross-sectional study. Nephrol Dial Transplant 25: 545–551, 2010
23. Davies SJ, Davenport A: The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 86: 489–496, 2014